EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Nephrogenic Syndrome of Inappropriate Antidiuresis: Case Report and Genetic Perspectives

Xiao-Juan Chen iD, Min Kou, Mei Feng, Li-Hua Wang, Jing-Jing Wei

Nephrology · 2026

DOI: 10.1111/nep.70250 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephrology, 2026. Verfasst von Xiao-Juan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Genetics and Metabolism, Shanxi Children's Hospital, Taiyuan, China. Hauptthemen laut MEDLINE: Inappropriate ADH Syndrome, Receptors, Vasopressin, Mutation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To report a case of nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a de novo hemizygous hotspot variant (c.409C>T p.R137C) in the AVPR2 gene in a young male child, and to discuss the diagnostic approach, therapeutic management, and follow‐up of NSIAD.

Methods

A 3‐year and 2‐month‐old male child presenting with intermittent convulsions persisting for over one year and chronic hyponatremia was clinically evaluated. Genetic testing was performed to identify potential causative variants. Water restriction therapy was implemented, with the patient spontaneously limiting water intake to prevent infections and regulating fluid intake during illnesses. Follow‐up evaluations were conducted at 3 and 6 months.

Results

Genetic testing identified a de novo hemizygous hotspot variant, c.409C>T (p.R137C), in the AVPR2 gene. The patient adhered to spontaneous water restriction and regulated fluid intake during illnesses. Follow‐up evaluations at 3 and 6 months demonstrated normal serum sodium levels, with no recurrence of convulsions or other symptoms.

Conclusion

NSIAD should be included in the differential diagnosis of hyponatremia of unknown etiology. Genetic testing is crucial for achieving an early diagnosis, optimizing treatment regimens, and enhancing treatment compliance. Water restriction therapy, under careful monitoring, remains a safe and effective treatment modality, particularly during periods of illness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inappropriate ADH SyndromeReceptors, VasopressinMutationHumansMaleChild, PreschoolHyponatremiaGenetic Predisposition to DiseaseGenetic TestingPhenotypeTreatment OutcomeDNA Mutational AnalysisSodiumGenetic Diseases, X-Linked

Stichwörter der Autor:innen

AVPR2 geneGNAS genegenetic testinghyponatraemiapaediatric nephrogenic syndrome of inappropriate antidiuresis (NSIAD)water restriction

Substanzen

Receptors, VasopressinAVPR2 protein, humanSodium

Autor:innen und Institutionen

  • Department of Endocrinology, Genetics and Metabolism, Shanxi Children's Hospital, Taiyuan, China.
  • Department of Nephrology, Shanxi Children's Hospital, Taiyuan, China.
  • Department of Pediatrics, Shanxi Medical University, Taiyuan, China.

ORCID-Profile: Xiao-Juan Chen

Zitieren

APA

Chen, X. J., Kou, M., Feng, M., Wang, L. H., & Wei, J. J. (2026). Nephrogenic Syndrome of Inappropriate Antidiuresis: Case Report and Genetic Perspectives. Nephrology. https://doi.org/10.1111/nep.70250

Vancouver

Chen XJ, Kou M, Feng M, Wang LH, Wei JJ. Nephrogenic Syndrome of Inappropriate Antidiuresis: Case Report and Genetic Perspectives. Nephrology. 2026. doi:10.1111/nep.70250

BibTeX
@article{Chen2026,
  author = {Chen, Xiao-Juan and Kou, Min and Feng, Mei and Wang, Li-Hua and Wei, Jing-Jing},
  title = {Nephrogenic Syndrome of Inappropriate Antidiuresis: Case Report and Genetic Perspectives},
  journal = {Nephrology},
  year = {2026},
  doi = {10.1111/nep.70250}
}
Kostenlos starten →